Literature DB >> 4038653

Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4038653

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  5 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 2.  New agents in the treatment of primary brain tumors.

Authors:  S A Taylor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

4.  Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study.

Authors:  P Lunardi; J Osman Farah; L Mastronardi; F Puzzilli; F M Lo Bianco
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Effect of combined AZQ and radiation on the tolerance of the rat spinal cord.

Authors:  K K Ang; A J van der Kogel; E van der Schueren
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.